VISIONARY VOICES

In a conversation with IBT's Visionary Voices series, Dr. Claudia Kim, cosmetic surgeon and Chief Medical Officer at New York New Life, breaks down why the American cosmetic industry has exploded.

The safest jobs in the AI economy aren't the ones that sound impressive on a resume. They're the ones that sound dull on a job description but require...

The 10-year Treasury yield has broken above 4.5%. The 30-year is back above 5%. Morgan Stanley has warned that current yield levels are entering a danger zone.

This week's Visionary Voices continues our conversation with Eric Annan, founder of AYAHQ, on why real crypto utility isn't being built in New York or Singapore. It's being built in Accra, Nairobi, and Lagos.

At CES, McKinsey showed a version of the future that had nothing to do with investing directly, but everything to do with how to build towards wealth.

This week's Visionary Voices sits down with Eric Annan, founder of AYAHQ, one of West Africa's most outspoken entrepreneurs building at the intersection of tech, education, and human connection.

Zcash Has Rallied More Than 1,200% in 2026. Its Winklevoss-Backed Advisor Calls That "Background Noise."

Troy Snyder, Chairman of Wonderful Foundations, talks the evolving business landscape at CES, the need for radical re-thinking about the higher-education system, and the cost of "offloading" intellect to artificial intelligence.

This week's Visionary Voices sits down with Dan Bedford, founder of Clio, the messaging aggregation platform that wants to replace your chatbot with something customers actually want to use.

This week's Visionary Voices sits down with Archie Chaudhury and Ram Shanmugam, co-founders of LayerLens — the AI evaluation company building the trust layer for the agentic era.

Cyrus Norcross is a former Army Ranger, podcaster, and Native American civil rights advocate. He's a traveling journalist, avid dancer, and someone who has spent the years since Afghanistan trying to make sense of what American military intervention actually accomplishes — and what it doesn't.

"Performers are amongst the creators most vulnerable to unauthorised digital imitations," Pavis warned.

In a wide-ranging interview with International Business Times' Isaiah McCall, Ari Abelson, co-founder and president of Open Origins, warns that artificial intelligence will outpace human ability to discern from real and AI-generated images and videos.

In a wide-ranging interview with International Business Times' Isaiah McCall, Daniel Cittadino discussed the keys to building a business in volatile markets, artificial intelligence's impact in the construction space, and the future of entrepreneurship with rapidly developing technology.

In a wide-ranging interview with International Business Times' Isaiah McCall, Troy Snyder, Chairman of Wonderful Foundations, talks the evolving business landscape at CES, the need for radical re-thinking about the higher-education system, and the cost of "offloading" intellect to artificial intelligence.

"The way I'm seeing AI in the legal industry and the legal profession is twofold. AI, you could see it replacing interns and maybe first year associates. I also see it helping businesses or law firms increase their marketing."

In the United States, life insurance is a time-tested, conservative, and dependable financial product. But those very virtues make the industry slow to incorporate innovations.

When we sat down with entrepreneur Mitch Francis, author of "BAD-ASS SOLUTIONS: For Today's BIG-ASS Problems," we were expecting polite deficit talk or another PowerPoint solution. What we got instead was a blunt thesis.

IBT Visionary Voices' Stephen Dissette offers his thoughts on building lasting wealth in 2025

From cancer therapies to clean energy breakthroughs, the fruits of American innovation are transforming lives. But around the world, our strategic competitors are chipping away at the very framework that makes this possible -- intellectual property (IP) rights.

Big business lobbyists are winning an obscure -- but hugely consequential -- battle over the future of the judicial system. If these lobbyists continue to get their way, small businesses and their workers will be the biggest losers.

The good news for patients is that pharmaceutical products are not subject to these so-called "reciprocal tariffs" -- for now.